Hui Wang

Hui Wang

Auto-generated profile, based on publicly available information

Hui Wang

Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2024 in Cancer Research
Verified
Journal Article
Open access
XWXiaolin Wang
Xiaolin Wang
HWHui Wang
Hui Wang
ZLZhengjing Lu
Zhengjing Lu
XLXiangjun Liu
Xiangjun Liu
WCWenjia Chai
Wenjia Chai
JGJingang Gui
Jingang Gui
The dynamic interplay between tumor cells and γδT cells within the tumor microenvironment significantly influences disease progression and immunotherapy outcome. In this study, we delved into the modulation of γδT-cell activation by tumor cell ligands CD112 and CD155, which interact with the activating receptor DNAM-1 on γδT cells. Spatial and single-cell RNA sequencing, as well as spatial metabolomic analysis, from neuroblastoma revealed that the expression levels and localization of CD112 and CD155 varied across and within tumors, correlating with differentiation status, metabolic pathways, and ultimately disease prognosis and patient survival. Both in vivo tumor xenograft experiments and in vitro coculture experiments demonstrated that a high CD112/CD155 expression ratio in tumors enhanced γδT cell–mediated cytotoxicity, whereas a low ratio fostered tumor resistance. Mechanistically, CD112 sustained DNAM-1–mediated γδT-cell activation, whereas CD155 downregulated DNAM-1 expression via E3 ubiquitin ligase tripartite motif–containing 21–mediated ubiquitin proteasomal degradation. By interacting with tumor cells differentially expressing CD112 and CD155, intratumoral γδT cells exhibited varying degrees of activation and DNAM-1 expression, representing three major functional subsets. This study underscores the complexity of tumor–immune cross-talk, offering insights into how tumor heterogeneity shapes the immune landscape. Significance: Tumor cells in different intratumoral neighborhoods display divergent patterns of ligands that regulate γδT-cell activation, highlighting multilevel regulation of antitumor immunity resulting from the heterogeneity of intercellular interactions in the tumor microenvironment.

17 June 2026
Verified
Other
Open access
XWXiaolin Wang
Xiaolin Wang
HWHui Wang
Hui Wang
ZLZhengjing Lu
Zhengjing Lu
XLXiangjun Liu
Xiangjun Liu
WCWenjia Chai
Wenjia Chai
JGJingang Gui
Jingang Gui
Supplementary Figure 14 The effects of soluble CD155 or CD155 on NB cells on DNAM-1, PD-1, TIM-3 and TIGIT expression levels in γδT cells during the interaction with NB microenvironment. (A-C) α-CD155 is used in the co-culture of γδT cells and SH-SY5Y cells. DNAM-1, PD-1, TIM-3 and TIGIT are detected by FACS after 24 h co-culture (left) and MFI is labeled in the representative FACS histograms (right). (D-G) α-CD155 is used in the co-culture of γδT cells and primary NB tumor cells. DNAM-1, PD-1, TIM-3 and TIGIT expression are detected by FACS after 24 h co-culture (left) and MFI is labeled in the representative FACS histograms (right). (H-K) DNAM-1, PD-1, TIM-3 and TIGIT expression are detected by FACS after 24 h NB TTCS treatment (left) and MFI is labeled in the representative FACS histograms (right). The results are expressed as the means ± SEMs from at least three independent experiments. Significant differences between groups are represented by ns no significance, * p < 0.05 and ** p < 0.01.

17 June 2026
Verified
Other
Open access
XWXiaolin Wang
Xiaolin Wang
HWHui Wang
Hui Wang
ZLZhengjing Lu
Zhengjing Lu
XLXiangjun Liu
Xiangjun Liu
WCWenjia Chai
Wenjia Chai
JGJingang Gui
Jingang Gui
Supplementary Figure 7 Metabolic states of high-ratio and low-ratio tumor cells. (A) Enriched metabolic reactions in high-ratio and low-ratio tumor cells revealed by COMPASS analysis. (B) Changes in metabolic KEGG pathways revealed by spatial metabolome analysis. (C) The heatmaps of representing metabolites.

17 June 2026
Verified
Other
Open access
PDF file
XWXiaolin Wang
Xiaolin Wang
HWHui Wang
Hui Wang
ZLZhengjing Lu
Zhengjing Lu
XLXiangjun Liu
Xiangjun Liu
WCWenjia Chai
Wenjia Chai
JGJingang Gui
Jingang Gui
Supplementary Figure 13 The effects of CD155 on γδT-cell-cytotoxicity against neuroblastoma, and on proliferation and migration of NB cells. (A) and (B) α-TIGIT is used in the rhCD155 treatment of γδT cells. DNAM-1 is detected by FACS and Western blot. (C-F) rhCD155 is used to treat γδT cells for 24 h. TIGIT, CD96 and CD112R are detected by FACS (left) or Western blot and MFI is labeled in the representative FACS histograms (right). (G) γδT-cell numbers are counted and statistically analyzed during in vitro culture in presence of rhCD155. (H) The CFSE proliferation assays are performed during in vitro culture in presence of rhCD155. γδT cells are detected by FACS (right) and statistically analyzed (left). MFI is labeled in the representative FACS histograms. (I) γδT cells are pre-treated with rhCD155 for 24 h and subjected to calcium flux detection by Fluo-4 AM labeling and low-concentration PMA and ionomycin stimulation. The calcium flux results are used to benchmark the levels of activation. The results are recorded and illustrated by FACS (right) and statistically analyzed (left). (J) The phosphorylation of Akt and ERK1/2 in γδT cells is detected by Western blot after treatment using rhCD155 for 24 h. (K) and (L) The cytotoxicity assays are performed with γδT cells pre-treated with rhCD155 or α-TIGIT for 24 h and NB cell lines. (M) and (N) The cytotoxicity assays are performed to detected γδT-cell cytotoxicity against SH-SY5Y and CHLA-255 cells in presence of α-CD155. (O-Q) IFN-γ, perforin and granzyme B expression are detected by FACS upon PMA and ionomycin stimulation after rhCD155 pre-treatment (left) and MFI is labeled in the representative FACS histograms (right). (R-T) CCK-8, Transwell and wound-healing sassays are performed using SK-N-BE2-NC and SK-N-BE2-KoCD155 cells. Representative images of SK-N-BE2 cell migration obtained from the Transwell (magnification × 100) and wound-healing (magnification × 100) assays are shown (right). The cell numbers obtained from the Transwell assays are counted, and the relative migration rate obtained from the wound-healing assays is calculated by dividing the change in the distance between the scratch edges by the initial distance (left). (U) The phosphorylation of Akt and ERK1/2 in γδT cells is detected by Western blot after SK-N-BE2-NC and SK-N-BE2-KoCD155 stimulation. (V) TIGIT is detected by FACS after 24 h co-culture with SK-N-BE2-NC and SK-N-BE2-KoCD155 cells (left) and MFI is labeled in the representative FACS histograms (right). The results are expressed as the means ± SEMs from at least three independent experiments. Significant differences between groups are represented by ns no significance, * p < 0.05, ** p < 0.01 and *** p < 0.001.

17 June 2026
Verified
Other
Open access
PDF file
XWXiaolin Wang
Xiaolin Wang
HWHui Wang
Hui Wang
ZLZhengjing Lu
Zhengjing Lu
XLXiangjun Liu
Xiangjun Liu
WCWenjia Chai
Wenjia Chai
JGJingang Gui
Jingang Gui
Supplementary Figure 12 The effects of CD112 on γδT-cell-cytotoxicity against neuroblastoma, and on proliferation and migration of NB cells. (A-D) rhCD112 is used to treat γδT cells for 24 h. TIGIT, CD96 and CD112R are detected by FACS (left) or Western blot and MFI is labeled in the representative FACS histograms (right). (E) γδT-cell numbers are counted and statistically analyzed during in vitro culture in presence of rhCD112. (F) The CFSE proliferation assays are performed during in vitro culture in presence of rhCD112. γδT cells are detected by FACS (right) and statistically analyzed (left). MFI is labeled in the representative FACS histograms. (G) γδT cells are pre-treated with rhCD112 for 24 h and subjected to calcium flux detection by Fluo-4 AM labeling and low-concentration PMA and ionomycin stimulation. The calcium flux results are used to benchmark the levels of activation. The results are recorded and illustrated by FACS (right) and statistically analyzed (left). (H) The phosphorylation of Akt and ERK1/2 in γδT cells is detected by Western blot after treatment using rhCD112 with or without α-DNAM-1 for 24 h. (I) and (J) The cytotoxicity assays are performed with γδT cells pre-treated with rhCD112 for 24 h and NB cell lines. (K) and (L) The cytotoxicity assays are performed to detected γδT-cell cytotoxicity against SH-SY5Y and CHLA-255 cells in presence of α-CD112. (M-O) CCK-8, Transwell and wound-healing sassays are performed using CHLA-255-NC and CHLA-255-shCD112 cells. Representative images of CHLA-255 cell migration obtained from the Transwell (magnification × 100) and wound-healing (magnification × 100) assays are shown (right). The cell numbers obtained from the Transwell assays are counted, and the relative migration rate obtained from the wound-healing assays is calculated by dividing the change in the distance between the scratch edges by the initial distance (left). (P) CD112 is overexpressed in IMR-32 cells transiently by transfecting constructed CD112 vector and CD112 expression is detected by qPCR, FACS and Western blot. MFI is labeled in the representative FACS histograms. (Q) DNAM-1 reduction is detected by FACS after 24 h co-culture with IMR-32-vector or IMR-32-CD112 cells (left) and MFI is labeled in the representative FACS histograms (right). (R) The phosphorylation of Akt and ERK1/2 in γδT cells is detected by Western blot after CHLA-255-NC and CHLA-255-shCD112 stimulation. (S) The cytotoxicity assays are performed to detected γδT-cell cytotoxicity against IMR-32-vector and IMR-32-CD112 cells. The results are expressed as the means ± SEMs from at least three independent experiments. Significant differences between groups are represented by ns no significance, * p < 0.05, ** p < 0.01 and *** p < 0.001.